Andrew Moore

Andrew Moore, MS, is a seasoned research scientist with substantial experience in pharmacodynamics and clinical trial support at Prelude Therapeutics, where responsibilities include designing assays and collaborating with CROs. Moore previously held positions at QPS Holdings, LLC, focusing on validation and analysis projects within a GLP environment, and served as a graduate teaching assistant at the University of Delaware while conducting research on C. elegans. With a Master of Science in Molecular Biology and Genetics and a Bachelor of Arts in Biology from the University of Delaware, Moore’s academic foundation is complemented by prior roles in customer service and lifeguarding.